Epizyme welcome to Ipsen
Epizyme welcome to Ipsen
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
Epizyme welcome to Ipsen
- 12 August 2022 - 1 mins read
Hear what CEO David Loew has to say about the official close of its acquisition of Epizyme.
Related Stories
15 March 2024
2 mins read
Applications now open for the 2024 Golden Ticket competition
08 February 2024
0 mins read
FY 2023 results announcement
20 November 2023
1 mins read
Ipsen sponsors 5 elite athletes on their journeys to the 2024 Paralympics
10 November 2023
1 mins read
Examining the European Pharma legislation: EFPIA publishes the Dolon Report
03 November 2023
0 mins read
Capital Markets Day 2023
23 October 2023
1 mins read
2023 year to date and third-quarter sales results
20 July 2023
1 mins read
Winner of Ipsen’s golden ticket announced as newest resident of Biolabs Hôtel Dieu
07 July 2023
1 mins read
David Loew, Philippe Lopes Fernandes inaugurate Biolabs – Hôtel Dieu
01 June 2023
1 mins read
Ipsen’s 2022 Integrated Annual Report now available
02 November 2022
1 mins read